Filing Details

Accession Number:
0000874015-14-000021
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-01-17 19:40:26
Reporting Period:
2014-01-15
Filing Date:
2014-01-17
Accepted Time:
2014-01-17 19:40:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874015 Isis Pharmaceuticals Inc ISIS Pharmaceutical Preparations (2834) 330336973
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1074773 L Elizabeth Hougen C/O Isis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad CA 92010
Svp, Finance & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-01-15 654 $0.00 954 No 4 M Direct
Common Stock Disposition 2014-01-16 250 $47.08 704 No 4 S Direct
Common Stock Acquisiton 2014-01-15 542 $0.00 1,246 No 4 M Direct
Common Stock Disposition 2014-01-16 207 $47.08 1,039 No 4 S Direct
Common Stock Acquisiton 2014-01-15 313 $0.00 1,352 No 4 M Direct
Common Stock Disposition 2014-01-16 120 $47.08 1,232 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Acquisiton 2014-01-15 7,500 $0.00 7,500 $0.00
Common Stock Restricted Stock Units Disposition 2014-01-15 654 $0.00 654 $0.00
Common Stock Restricted Stock Units Disposition 2014-01-15 542 $0.00 542 $0.00
Common Stock Restricted Stock Units Disposition 2014-01-15 313 $0.00 313 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,500 No 4 A Direct
1,961 No 4 M Direct
1,082 No 4 M Direct
937 No 4 M Direct
Footnotes
  1. Acquired pursuant to vesting and release of shares pursuant to an RSU award granted on January 15, 2013.
  2. The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice, dated January 15, 2013.
  3. Acquired pursuant to vesting and release of shares pursuant to an RSU award granted on January 15, 2012.
  4. The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice, dated January 15, 2012.
  5. Each Restricted Stock Unit represents a contingent right to receive one share of Isis common stock, or its equivalent cash value.
  6. Grant 1/15/2014 to reporting person of Restricted Stock Units under the Isis Pharmaceuticals, Inc. 2011 Equity Incentive Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on January 15, 2015. Upon vesting, the restricted stock units will be paid out in whole shares of Isis common stock or cash as may be determined by the Company. The RSU shall be fully vested on January 15, 2018. The RSU is vested as to 0 shares on January 15, 2014.
  7. Restricted Stock Unit Award granted on January 15, 2013. Restricted Stock Units vest in equal annual installments, the first installment vested on January 15, 2014. Upon vesting, the restricted stock units will be paid out in whole shares of Isis common stock or cash as may be determined by the Company. The RSU shall be fully vested on January 15, 2017.
  8. Restricted Stock Unit Award granted on January 15, 2012. Restricted Stock Units vest in equal annual installments, the first installment vested on January 15, 2013. Upon vesting, the restricted stock units will be paid out in whole shares of Isis common stock or cash as may be determined by the Company. The RSU shall be fully vested on January 15, 2016.